Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    North America Immunohematology Market Forecast 2028 By Technology (Biochips, Gel Cards, Microplates, Polymerase Chain Reaction, Erythrocyte-magnetized technology (EMT)), By Product (Analyzers, Reagents), By End Use (Hospitals, Diagnostic Laboratories, Blood Banks), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
    Published Date: November 2022   |   Report ID: GR1291   |   Delivery: PDF  Request Free Sample

    North America Immunohematology Market size surpassed USD 840 million in 2021 and is expected to grow at 4% CAGR between 2022 and 2028. The growing number of blood transfusions across the region is supporting the market growth. In the United States, a patient needs blood about every two seconds. With the number of chronic illnesses, traumatic injuries, and cancer incidences on the rise, the need for plasma and blood donation is increasing.

    North America Immunohematology Market

    Get more details on this report - Request Free Sample PDF

    Medical facilities are focusing on the expansion of top-notch infrastructure across the U.S. as well as Canada. Recently, in October 2022, the Children's Oncology Hematologic Clinic (COHC), a subsidiary of KIDZ Medical Services, announced the inauguration of its new practice in West Palm Beach in Florida. The facility will provide specialized care to children and teenagers for lymphoma, leukemia, brain tumors, bone marrow-related illnesses, solid tumors, bone marrow transplants, and a host of blood disorders.

    COVID-19 virus Impact on North America immunohematology market outlook

    The novel coronavirus pandemic impacted the healthcare sector in many ways. There was increased need for developing effective diagnostic products. Manufacturers are introducing innovative devices that minimize dependence on skilled personnel. According to a pre-pandemic survey conducted by the American Society of Hematology (ASH), nearly half of the total number of practices and hospitals across the country were already short of skilled hematologists. With this situation being exacerbated by the outbreak of SARS-CoV-2, the ASH committed over USD 20 million to a training program for hematologists. With hematology research on the agenda of the organization, the emergence of cutting-edge technologies is on the horizon in academia and in the market.

    North America Market, By Product

    The analyzers & systems product segment accounted for USD 290 million revenue in 2021, owing the rising number of premature births and childbirth-related complications are fueling the need for better blood transfer infrastructure. Several hospitals in the U.S. are investing in these devices, as they help sustain the lives of not only new mothers but also their premature babies. The government is investing in the development of a robust, easily accessible blood supply throughout the national healthcare system.

    North America Market, By Technology

    The biochips segment in the North America immunohematology market will cross USD 130 million revenue by 2028. This technology is gaining traction with a rise in investments supporting DNA diagnostics that rely on these platforms. As investments in cancer and elderly patient care are growing, product manufacturers will profit from an abundance of market opportunities. Biochips offer benefits such as simultaneous qualitative or qualitative detection across a range of analytes from a single sample. The technology can assist in toxicological, biological and protein research, expanding the industry scope.

    North America Immunohematology Market, By End-use

    The diagnostic laboratories will witness a lucrative growth during the forecast timeframe. These facilities provide advantages such as fast results, ability to procure advanced equipment and wider access. The number patients with diseases such as HIV, anaemia, lymphoma, leukaemia, and myeloma is growing in North America. Higher awareness about early detection of these disorders will augment the demand for immunohematology products across diagnostic labs.

    Competitive Industry Landscape

    Some of the leading companies operating in the North America immunohematology market are Roche Diagnostics, Siemens Healthcare GmbH, Thermo Fisher Scientific, Abbott, Hologic, and Beckman Coulter.

    Companies are joining hands to simplify laboratory operations and improve workflows. To cite an instance, in July 2022, Beckman Coulter, a top provider of clinical diagnostic solutions, announced that it has found a partnership with Scorpio Labs a MedTech company developing AI-powered workflow solutions. The new solution will eliminate dependence on manual microscopy by providing access to high-resolution full-field images that can be shared in real-time across the healthcare network.

    Frequently Asked Question(FAQ) :

    What is the value of immunohematology market in North America?
    The market value for immunohematology in North America was more than USD 840 million in 2021 and is expected to register over 4% CAGR between 2022 and 2028.
    Why is the demand for immunohematology analyzers & systems growing in North America?
    The market share for immunohematology in North America from the analyzers & systems product segment surpassed USD 290 million during 2021, with increasing need for automated analyzers and the focus on minimizing manual errors.
    How does biochip technology impact North America immunohematology industry?
    The market share for immunohematology in North America from biochips technology will surpass USD 130 million by 2028, owing to numerous benefits, such as simultaneous qualitative or qualitative detection across a range of analytes from a single sample.
    Who provides immunohematology products in North America?
    Some of the key players in the market are Roche Diagnostics, Siemens Healthcare GmbH, Thermo Fisher Scientific, Abbott, Hologic, and Beckman Coulter, among others.

    Get this research report on North America Immunohematology Market customized according to your business requirements.

    report-purchase - logo Buy Now

    Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team


     [email protected]